191 related articles for article (PubMed ID: 19581128)
1. Type II transmembrane serine proteases in cancer and viral infections.
Choi SY; Bertram S; Glowacka I; Park YW; Pöhlmann S
Trends Mol Med; 2009 Jul; 15(7):303-12. PubMed ID: 19581128
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections.
Ohler A; Becker-Pauly C
Biol Chem; 2012 Sep; 393(9):907-14. PubMed ID: 22944691
[TBL] [Abstract][Full Text] [Related]
3. Roles and regulation of membrane-associated serine proteases.
Qiu D; Owen K; Gray K; Bass R; Ellis V
Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
[TBL] [Abstract][Full Text] [Related]
4. Role of TMPRSS4 during cancer progression.
Choi SY; Shin HC; Kim SY; Park YW
Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
[TBL] [Abstract][Full Text] [Related]
5. Type II transmembrane serine proteases in development and disease.
Szabo R; Bugge TH
Int J Biochem Cell Biol; 2008; 40(6-7):1297-316. PubMed ID: 18191610
[TBL] [Abstract][Full Text] [Related]
6. The role of type II transmembrane serine protease-mediated signaling in cancer.
Tanabe LM; List K
FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
[TBL] [Abstract][Full Text] [Related]
7. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro.
Stallmach R; Gloor SM
Biochem J; 2008 May; 412(1):81-91. PubMed ID: 18215125
[TBL] [Abstract][Full Text] [Related]
8. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.
Netzel-Arnett S; Hooper JD; Szabo R; Madison EL; Quigley JP; Bugge TH; Antalis TM
Cancer Metastasis Rev; 2003; 22(2-3):237-58. PubMed ID: 12784999
[TBL] [Abstract][Full Text] [Related]
9. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
[TBL] [Abstract][Full Text] [Related]
10. Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
Viloria CG; Peinado JR; Astudillo A; García-Suárez O; González MV; Suárez C; Cal S
Br J Cancer; 2007 Jul; 97(2):201-9. PubMed ID: 17579619
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
Murza A; Dion SP; Boudreault PL; Désilets A; Leduc R; Marsault É
Expert Opin Ther Pat; 2020 Nov; 30(11):807-824. PubMed ID: 32887532
[TBL] [Abstract][Full Text] [Related]
12. Matriptase: a culprit in cancer?
List K
Future Oncol; 2009 Feb; 5(1):97-104. PubMed ID: 19243302
[TBL] [Abstract][Full Text] [Related]
13. Type II transmembrane serine proteases.
Szabo R; Wu Q; Dickson RB; Netzel-Arnett S; Antalis TM; Bugge TH
Thromb Haemost; 2003 Aug; 90(2):185-93. PubMed ID: 12888865
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
Kim S
Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
[TBL] [Abstract][Full Text] [Related]
15. The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
Sanders AJ; Webb SL; Parr C; Mason MD; Jiang WG
Anticancer Agents Med Chem; 2010 Jan; 10(1):64-9. PubMed ID: 20015002
[TBL] [Abstract][Full Text] [Related]
16. Type II transmembrane serine proteases as potential targets for cancer therapy.
Murray AS; Varela FA; List K
Biol Chem; 2016 Sep; 397(9):815-26. PubMed ID: 27078673
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
18. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
19. Type II transmembrane serine protease (TTSP) deregulation in cancer.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Front Biosci (Landmark Ed); 2011 Jan; 16(2):539-52. PubMed ID: 21196187
[TBL] [Abstract][Full Text] [Related]
20. Type II transmembrane serine proteases.
Bugge TH; Antalis TM; Wu Q
J Biol Chem; 2009 Aug; 284(35):23177-81. PubMed ID: 19487698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
